About the Journal

BIOI cover 2026

Volume 7, 2026

Online Edition: ISSN 2712-0082  

Co-Editor-in-Chief:  Pintong Huang
Professor
Zhejiang University, Hangzhou, China

Co-Editor-in-Chief:  Chaozong Liu
Professor
University College London, London, United Kingdom

Executive Editor: Zhiwen Luo
Principal Investigator
Fudan Zhangjiang Institute, Fudan University, Shanghai, China

 

BIOI launched in 2020; previously published in 4 issues per volume, the journal has adopted a continuous article publication process from 2024. Volume 7 will publish in 2026.

LBNPs improve tumor-directed drug delivery through passive, active, and responsive targeting, enhancing efficacy while reducing adverse effects. #Oncology #LBNP @UUDehradun
#BIOI #OpenAccess: https://doi.org/10.15212/bioi-2024-0107

Can biophysical stimulation modernize acupuncture-inspired therapies?
LIPUS offers non-invasive acupoint stimulation that modulates neural, immune & cellular pathways involved in inflammation & tissue repair. #BiomedicalEngineering
#BIOI #OpenAccess: https://doi.org/10.15212/bioi-2025-0196

Engineered Extracellular Vesicles: Advancing Cancer Therapy Through Precision Nanomedicine. Click the link below to read this #open_access article.

BIO Integration is indexed in EBSCO, EMBASE, Scopus, CAS, DOAJ, Research4Life, Ulrich’s web, OCLC, WorldCat, Primo Central (Ex Libris), Sherpa Romeo, CNKI Scholar (Chinese National Knowledge Infrastructure) and Summon Databases.